In another study, SERPINA3 was identified as a potential predictive marker of clinical outcome after myocardial infarction, as the level of this protease inhibitor was found to be directly correlated with other measured inflammatory markers (30). This evidence concerns the gene SERPINA3 and myocardial infarction.